Evidence map›Paper›PMID 28977960›Full record

ArticleOncotarget2017

Association between

Kun Liu, Xuzhong Liu, Shuo Gu, Qing Sun, Yunyan Wang, Junsong Meng, Zongyuan Xu

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kun LiuDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Xuzhong LiuDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Shuo GuDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Qing SunDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Yunyan WangDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Junsong MengDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Zongyuan XuDepartment of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, 223300 China.
Nanjing Medical University · CNHuaian First People’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological studies have investigated the role of transforming growth factor-β1 (TGF-β1) in chronic allograft dysfunction (CAD) following kidney transplantation. MATERIALS AND

methodsMEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Embase, the Chinese CNKI and WANFANG databases were searched. Data were extracted and pooled results were estimated from odds ratios (ORs) with 95% confidential intervals (95% CIs). Quality assessments were performed, and publication bias of all eligible studies examined.

resultsEight studies with 1038 subjects were included in our analysis. According to the effects on TGF-β1 secretion, haplotypes were categorized as "HIGH", "INTERMEDIATE" and "LOW". The combined results showed a statistically significant difference of

conclusionsOur meta-analysis has found the haplotype of

Indexed as

chronic allograft dysfunctionmeta-analysispolymorphismTGFB1

Identifiers

PMID28977960
PMCPMC5617520
OpenAlexW2739006670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.